Nanomaterials In Personalized Medicine Industry Growth Insights: Revenue Forecast to 2030
Uncover key drivers, emerging technologies, and competitive movements shaping the nanomaterials in personalized medicine market from 2026–2035 with trusted insights from The Business Research Company
What are the forecasted starting (2026) and ending (2030) market sizes for the Nanomaterials In Personalized Medicine Market?
The market for nanomaterials in personalized medicine has seen rapid expansion in recent years. Its valuation is expected to rise from $392.97 billion in 2025 to $438.79 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.7%. This past growth can be attributed to developments in genomics and molecular biology, increased adoption of targeted therapies, an expansion of translational medical research, the accessibility of advanced nanofabrication techniques, and a rise in academic-industry collaborations.
The market size for nanomaterials in personalized medicine is projected to experience substantial expansion over the upcoming years. By 2030, this market is forecasted to reach $674.28 billion, driven by a compound annual growth rate (CAGR) of 11.3%. This projected growth during the forecast timeframe is attributable to several factors: a surging demand for tailored healthcare approaches, increased capital flow into precision medicine initiatives, the expanding application of nanomaterials in diagnostic tools and imaging, a heightened emphasis on reducing adverse effects of therapies, and ongoing advancements in medical technologies that utilize nanotechnology. Key trends observed within this forecast period encompass the escalating utilization of targeted nanomaterials for customized treatments, the increasing incorporation of molecular diagnostics with nanotechnology, a growing uptake of nanomaterials for precise drug administration, the broadening scope of nanotechnology in regenerative medicine, and a stronger emphasis on treatment results specific to individual patients.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28276&type=smp
What Drivers Are Supporting Technological Adoption In The Nanomaterials In Personalized Medicine Market?
The expanding need for individualized healthcare is anticipated to drive the future growth of the nanomaterials in personalized medicine market. Personalized medicine is a medical approach that customizes treatments for individual patients based on their genetic, environmental, and lifestyle factors to optimize outcomes and improve care. This increasing demand is fueled by advancements in genomic technologies, which allow for the precise identification of genetic variations and the creation of tailored treatments for individuals. Nanomaterials play a role in enhancing personalized medicine by enabling targeted and patient-specific therapies, which in turn improve treatment efficacy and safety. They facilitate the precise delivery of drugs, genes, or RNA, thereby reducing side effects and optimizing therapeutic outcomes. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, stated that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, marking a considerable increase from the 12 approved in 2022. Thus, the rising demand for personalized medicine is a key driver for the growth of the nanomaterials in personalized medicine market.
What Segment Types Are Examined In The Nanomaterials In Personalized Medicine Market?
The nanomaterials in personalized medicine market covered in this report is segmented –
1) By Type Of Nanomaterials: Carbon-Based Nanomaterials, Metallic Nanoparticles, Polymeric Nanomaterials, Nanostructured Materials, Silica Nanoparticles
2) By Formulation Type: Nanoparticles, Nanosuspensions, Nanoemulsions, Nanocrystals, Nanoformulations For Targeted Delivery
3) By Technology Utilized: Nanofabrication Techniques, Bioconjugation Methods, Surface Modification Techniques, Molecular Imaging Techniques, Nanotechnology-Based Screening Methods
4) By Application Areas: Drug Delivery Systems, Diagnostics And Imaging, Therapeutics, Regenerative Medicine, Vaccines
5) By End-Users: Hospitals And Clinics, Research Laboratories, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions
Subsegments:
1) By Carbon-Based Nanomaterials: Fullerenes, Carbon Nanotubes, Graphene, Carbon Dots
2) By Metallic Nanoparticles: Gold Nanoparticles, Silver Nanoparticles, Iron Oxide Nanoparticles, Copper Nanoparticles
3) By Polymeric Nanomaterials: Dendrimers, Micelles, Polymeric Nanoparticles, Hydrogels
4) By Nanostructured Materials: Quantum Dots, Nanowires, Nanosheets, Nanorods
5) By Silica Nanoparticles: Mesoporous Silica Nanoparticles, Colloidal Silica Nanoparticles, Porous Silica Nanoparticles, Functionalized Silica Nanoparticles
What Trends Are Driving The Growth Trajectory Of The Nanomaterials In Personalized Medicine Market?
Key entities active within the nanomaterials in personalized medicine market are prioritizing strategic collaborations to expedite clinical application, broaden therapeutic uses, and reduce the time to market, all while adhering to evolving regulatory frameworks. These strategic partnerships involve companies or organizations pooling their specialized knowledge and resources to drive innovation and extend possibilities within personalized medicine. As an illustration, in May 2025, Acuitas Therapeutics Inc., a Canada-based biotechnology company, partnered with Integrated DNA Technologies Inc., a US-based genomics solutions provider, to unveil a personalized CRISPR gene-editing therapy delivery mechanism leveraging their lipid nanoparticles platform, which was successfully administered to an infant suffering from a rare genetic disorder. This treatment was characterized by accurately targeted CRISPR components, individualized dose modulation, and swift customized preparation. This advancement expedites highly bespoke, singular treatments. It enhances therapeutic accuracy and patient recovery, yet introduces complexities regarding large-scale production, rigorous regulatory adjustments, and extremely limited volume manufacturing.
Who Are The Top-Performing Companies In The Nanomaterials In Personalized Medicine Market In Recent Years?
Major companies operating in the nanomaterials in personalized medicine market are Pfizer & Co. Inc., BASF SE, Sanofi S.A., The Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA Darmstadt Germany, Evonik Industries AG, Eisai Co. Ltd., TÜV Rheinland AG, OCSiAl S.A., American Elements Inc., Cour Pharmaceuticals Inc., Nanocomposix Inc., NoPo Nanotechnologies Private Limited, Matexcel Biotech Inc., OncoNano Medicine Inc., Molecular Rebar Design Inc., Cello Therapeutics Inc., Apurano Pharmaceuticals GmbH, SGN Nanopharma Inc.
Access The Complete Report For Deeper Market Insights:
Which Region Currently Holds The Largest Share Of The Nanomaterials In Personalized Medicine Market?
North America was the largest region in the nanomaterials in personalized medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomaterials in personalized medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Nanomaterials In Personalized Medicine Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=28276&type=smp
Browse Through More Reports Similar to the Global Nanomaterials In Personalized Medicine Market 2026, By The Business Research Company
Nanomaterials In Cosmetic And Personal Care Market Report 2026
Nanomedicine Market Report 2026
https://www.thebusinessresearchcompany.com/report/nanomedicine-global-market-report
Healthcare Nanotechnology Market Report 2026
https://www.thebusinessresearchcompany.com/report/healthcare-nanotechnology-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
